SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Manav V. Vyas, Benjamin Andrew Davidson, Leonardo Escalaya, John Costella, Gustavo Saposnik, Jorge G. Burneo, Antiepileptic drug use for treatment of epilepsy and dyslipidemia: Systematic review, Epilepsy Research, 2015, 113, 44

    CrossRef

  2. 2
    Nobustune Ishikawa, Yoshiyuki Kobayashi, Yuji Fujii, Masao Kobayashi, Increased interleukin-6 and high-sensitivity C-reactive protein levels in pediatric epilepsy patients with frequent, refractory generalized motor seizures, Seizure, 2015, 25, 136

    CrossRef

  3. 3
    Kartik Sivaraaman, Vimala S. Vajjala, Seizures in Setting of Dementia, Current Treatment Options in Neurology, 2015, 17, 4

    CrossRef

  4. 4
    Elham Amini, Mohsen Rezaei, Norlinah Mohamed Ibrahim, Mojtaba Golpich, Rasoul Ghasemi, Zahurin Mohamed, Azman Ali Raymond, Leila Dargahi, Abolhassan Ahmadiani, A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts, Molecular Neurobiology, 2014,

    CrossRef

  5. 5
    Sherifa A. Hamed, Atherosclerosis in epilepsy: Its causes and implications, Epilepsy & Behavior, 2014, 41, 290

    CrossRef

  6. You have free access to this content6
    K E Caudle, A E Rettie, M Whirl-Carrillo, L H Smith, S Mintzer, M T M Lee, T E Klein, J T Callaghan, Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing, Clinical Pharmacology & Therapeutics, 2014, 96, 5
  7. 7
    Ayse Esin Kibar, Olcay Unver, Mehmet Burhan Oflaz, Ahmet Sami Güven, Sevket Balli, İbrahim Ece, Sevcan Erdem, Fusun Dilara İçağasıoğlu, Effect of Antiepilepsy Drug Therapy on Ventricular Function in Children With Epilepsy: A Tissue Doppler Imaging Study, Pediatric Cardiology, 2014, 35, 2, 280

    CrossRef

  8. 8
    Forayssa M. Talaat, Tayssir Kamel, Amany M. Rabah, Sandra M. Ahmed, Shaimaa I. El-Jaafary, Ghada H. Abdelaziz, Epilepsy and antiepileptic drugs: risk factors for atherosclerosis, International Journal of Neuroscience, 2014, 140924103426003

    CrossRef

  9. 9
    Basma S Haggag, Amany H Hasanin, Mona H Raafat, Hala S Abdel Kawy, Lamotrigine Decreased Hippocampal Damage and Improved Vascular Risk Markers in a Rat Model of Pentylenetetrazole Induced Kindling Seizure, The Korean Journal of Physiology & Pharmacology, 2014, 18, 3, 269

    CrossRef

  10. 10
    Scott Mintzer, Plumbing and wiring: Atherosclerosis in epilepsy, Epilepsy & Behavior, 2014, 41, 274

    CrossRef

  11. 11
    S. Nia, Psychiatric signs and symptoms in treatable inborn errors of metabolism, Journal of Neurology, 2014, 261, S2, 559

    CrossRef

  12. 12
    Elisabetta Patorno, Robert J. Glynn, Sonia Hernández-Díaz, Jun Liu, Sebastian Schneeweiss, Studies with Many Covariates and Few Outcomes, Epidemiology, 2014, 25, 2, 268

    CrossRef

  13. 13
    Niki Katsiki, Dimitri P. Mikhailidis, Devaki R. Nair, The effects of antiepileptic drugs on vascular risk factors: A narrative review, Seizure, 2014, 23, 9, 677

    CrossRef

  14. 14
    Scott Mintzer, Vittorio Maio, Kathleen Foley, Use of antiepileptic drugs and lipid-lowering agents in the United States, Epilepsy & Behavior, 2014, 34, 105

    CrossRef

  15. 15
    Parra Jaime, ¿Qué aportan los nuevos fármacos antiepilépticos?, Revista Médica Clínica Las Condes, 2013, 24, 6, 995

    CrossRef

  16. 16
    Nathalie Jette, Hyunmi Choi, Samuel Wiebe, Applying evidence to patient care: From population health to individual patient values, Epilepsy & Behavior, 2013, 26, 3, 234

    CrossRef

  17. 17
    Cheng-Yang Hsieh, Edward Chia-Cheng Lai, Yea-Huei Kao Yang, Swu-Jane Lin, Comparative stroke risk of antiepileptic drugs in patients with epilepsy, Epilepsia, 2013, 54, 1
  18. 18
    Vimal Kumar, Anju Aggarwal, Sangeeta Sharma, Neelam Chillar, Hema Mittal, M. M. A. Faridi, Effect of carbamazepine therapy on homocysteine, vitamin B12 and folic acid levels in children with epilepsy, Indian Pediatrics, 2013, 50, 5, 469

    CrossRef

  19. 19
    Dong Wook Kim, Seo-Young Lee, Young-Min Shon, Ji Hyun Kim, Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy, Epilepsia, 2013, 54, 10
  20. You have free access to this content20
    Martin J. Brodie, Scott Mintzer, Alison M. Pack, Barry E. Gidal, Charles J. Vecht, Dieter Schmidt, Enzyme induction with antiepileptic drugs: Cause for concern?, Epilepsia, 2013, 54, 1
  21. 21
    Kanitpong Phabphal, Alan Geater, Kitti Limapichart, Pornchai Sathirapanya, Suwanna Setthawatcharawanich, Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients, Seizure, 2013, 22, 2, 103

    CrossRef

  22. 22
    Sophia Pan Wang, Scott Mintzer, Christopher T. Skidmore, Tingting Zhan, Erika Stuckert, Maromi Nei, Michael R. Sperling, Seizure recurrence and remission after switching antiepileptic drugs, Epilepsia, 2013, 54, 1
  23. 23
    J. Novy, M. Belluzzo, L. O. Caboclo, C. B. Catarino, M. Yogarajah, L. Martinian, J. L. Peacock, G. S. Bell, M. J. Koepp, M. Thom, J. W. Sander, S. M. Sisodiya, The lifelong course of chronic epilepsy: the Chalfont experience, Brain, 2013, 136, 10, 3187

    CrossRef

  24. 24
    Athanasios Gaitatzis, Josemir W. Sander, The Long-Term Safety of Antiepileptic Drugs, CNS Drugs, 2013, 27, 6, 435

    CrossRef

  25. 25
    Piero Perucca, Frank G Gilliam, Adverse effects of antiepileptic drugs, The Lancet Neurology, 2012, 11, 9, 792

    CrossRef

  26. 26
    Jacqueline A. French, Brigid A. Staley, AED Treatment Through Different Ages: As Our Brains Change, Should Our Drug Choices Also?, Epilepsy Currents, 2012, 12, 4s, 22

    CrossRef

  27. 27
    Bassel W Abou-Khalil, Another option for first-line treatment of partial epilepsy?, The Lancet Neurology, 2012, 11, 7, 568

    CrossRef

  28. 28
    Vincenzo Belcastro, Pasquale Striano, Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy, Epilepsy Research, 2012, 102, 1-2, 1

    CrossRef

  29. 29
    Scott Mintzer, Christopher T. Skidmore, Michael R. Sperling, B-Vitamin deficiency in patients treated with antiepileptic drugs, Epilepsy & Behavior, 2012, 24, 3, 341

    CrossRef

  30. 30
    Tiina Alapirtti, Matti Waris, Mahdi Fallah, Merja Soilu-Hänninen, Riikka Mäkinen, Elham Kharazmi, Jukka Peltola, C-reactive protein and seizures in focal epilepsy: A video-electroencephalographic study, Epilepsia, 2012, 53, 5
  31. 31
    K. Phabphal, K. Limapichat, P. Sathirapanya, S. Setthawatcharawanich, A. Geater, Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population, European Journal of Neurology, 2012, 19, 9
  32. 32
    Scott Mintzer, Christopher T. Skidmore, Sara J. Rankin, Inna Chervoneva, Edward Pequinot, David M. Capuzzi, Michael R. Sperling, Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein, Epilepsy Research, 2012, 98, 1, 88

    CrossRef

  33. 33
    Hans Rittmannsberger, Johannes Fellinger, Christian Foff, Gertraud Walli, Thomas Zaunmüller, Deterioration of metabolic parameters during short-term psychiatric inpatient treatment: A prospective naturalistic study, International Journal of Psychiatry in Clinical Practice, 2012, 16, 1, 8

    CrossRef

  34. 34
    Yao-Chung Chuang, Hung-Yi Chuang, Tsu-Kung Lin, Chiung-Chih Chang, Cheng-Hsien Lu, Wen-Neng Chang, Shang-Der Chen, Teng-Yeow Tan, Chi-Ren Huang, Samuel H. H. Chan, Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis, Epilepsia, 2012, 53, 1
  35. 35
    E. Trinka, Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?, Acta Neurologica Scandinavica, 2012, 126,
  36. 36
    Kyoung Heo, New antiepileptic drugs, Journal of the Korean Medical Association, 2012, 55, 2, 155

    CrossRef

  37. 37
    Stefan Beyenburg, Knut Stavem, Dieter Schmidt, Placebo-corrected efficacy of modern nonenzyme-inducing AEDs for refractory focal epilepsy: Systematic review and meta-analysis, Epilepsia, 2012, 53, 3
  38. 38
    Scott Mintzer, Plaques on the Wall: Inducing Anticonvulsant Use and Atherogenesis, Epilepsy Currents, 2012, 12, 6, 229

    CrossRef

  39. 39
    Jan Novy, Enrique Castelao, Martin Preisig, Pedro Marques Vidal, Gérard Waeber, Peter Vollenweider, Andrea O. Rossetti, Psychiatric co-morbidities and cardiovascular risk factors in people with lifetime history of epilepsy of an urban community, Clinical Neurology and Neurosurgery, 2012, 114, 1, 26

    CrossRef

  40. 40
    Vincenzo Belcastro, Pasquale Striano, Vascular risk in epilepsy patients: is antiepileptic treatment the key?, Pharmacoepidemiology and Drug Safety, 2012, 21, 2
  41. 41
    Alla Guekht, Natan M. Bornstein, Epilepsy, 2012,

    CrossRef

  42. 42
    Bassel W. Abou-Khalil, Martin J. Gallagher, Robert L. Macdonald, Neurology in Clinical Practice, 2012,

    CrossRef

  43. 43
    Natalia Lampon, J. Carlos Tutor, A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid, Upsala Journal of Medical Sciences, 2011, 116, 2, 148

    CrossRef

  44. 44
    C Michael Dunham, Thomas J Chirichella, Attenuated hypocholesterolemia following severe trauma signals risk for late ventilator-associated pneumonia, ventilator dependency, and death: a retrospective study of consecutive patients, Lipids in Health and Disease, 2011, 10, 1, 42

    CrossRef

  45. 45
    Inna Chervoneva, Mark Vishnyakov, Constrained S-estimators for linear mixed effects models with covariance components, Statistics in Medicine, 2011, 30, 14
  46. 46
    P. U. Feig, S. Shah, A. Hermanowski-Vosatka, D. Plotkin, M. S. Springer, S. Donahue, C. Thach, E. J. Klein, E. Lai, K. D. Kaufman, Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome, Diabetes, Obesity and Metabolism, 2011, 13, 6
  47. 47
    Jonas Bjerring Olesen, Steen Zabell Abildstrøm, Jesper Erdal, Gunnar H. Gislason, Peter Weeke, Charlotte Andersson, Christian Torp-Pedersen, Peter Riis Hansen, Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study, Pharmacoepidemiology and Drug Safety, 2011, 20, 9
  48. 48
    Jonas Bjerring Olesen, Peter Riis Hansen, Steen Zabell Abildstrøm, Charlotte Andersson, Peter Weeke, Michelle Schmiegelow, Jesper Erdal, Christian Torp-Pedersen, Gunnar Hilmar Gislason, Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study, Pharmacoepidemiology and Drug Safety, 2011, 20, 2
  49. 49
    Joyce A Cramer, Scott Mintzer, James Wheless, Richard H Mattson, Adverse effects of antiepileptic drugs: a brief overview of important issues, Expert Review of Neurotherapeutics, 2010, 10, 6, 885

    CrossRef

  50. 50
    Bulent Oguz Genc, Ebru Apaydın Dogan, Umuttan Dogan, Emine Genc, Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment, Journal of Clinical Neuroscience, 2010, 17, 10, 1256

    CrossRef

  51. 51
    S. Svalheim, G. Luef, M. Rauchenzauner, L. Mørkrid, L. Gjerstad, E. Taubøll, Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine, Acta Neurologica Scandinavica, 2010, 122,
  52. 52
    Natalia Lampón, J. Carlos Tutor, Effect of valproic acid treatment on copper availability in adult epileptic patients, Clinical Biochemistry, 2010, 43, 13-14, 1074

    CrossRef

  53. 53
    Alan W.C. Yuen, Gail S. Bell, Janet L. Peacock, Matthias M. Koepp, Philip N. Patsalos, Josemir W. Sander, Effects of AEDs on biomarkers in people with epilepsy: CRP, HbA1c and eGFR, Epilepsy Research, 2010, 91, 2-3, 187

    CrossRef

  54. 54
    M.J. Brodie, Effects of Antiepileptic Drugs on Lipids, Homocysteine, and C-Reactive Protein, Yearbook of Neurology and Neurosurgery, 2010, 2010, 43

    CrossRef

  55. 55
    Vincenzo Belcastro, Pasquale Striano, Gaetano Gorgone, Cinzia Costa, Clotilde Ciampa, Daniela Caccamo, Laura R. Pisani, Giancarla Oteri, Maria G. Marciani, Umberto Aguglia, Salvatore Striano, Riccardo Ientile, Paolo Calabresi, Francesco Pisani, Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs, Epilepsia, 2010, 51, 2
  56. 56
    Scott Mintzer, Metabolic consequences of antiepileptic drugs, Current Opinion in Neurology, 2010, 23, 2, 164

    CrossRef

  57. 57
    Derek J. Chong, Carl W. Bazil, Update on Anticonvulsant Drugs, Current Neurology and Neuroscience Reports, 2010, 10, 4, 308

    CrossRef

  58. 58
    Vincenzo Belcastro, Pasquale Striano, Cardiovascular disease in epileptic patients: How to assess the clinical risk?, Annals of Neurology, 2009, 66, 6
  59. 59
    Amir M. Arain, Bassel W. Abou-Khalil, Management of new-onset epilepsy in the elderly, Nature Reviews Neurology, 2009, 5, 7, 363

    CrossRef

  60. 60
    Patrick Kwan, Michael R. Sperling, Refractory seizures: Try additional antiepileptic drugs (after two have failed) or go directly to early surgery evaluation?, Epilepsia, 2009, 50,
  61. 61
    Scott Mintzer, Richard T. Mattson, Should enzyme-inducing antiepileptic drugs be considered first-line agents?, Epilepsia, 2009, 50,